CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 254 enrolled
Drug / intervention
Usual care mailing intervention +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00873288
NCT00873288N/ACompleted
CompareCT.gov

Activating Collaborative CIS Support Via Targeted Provider Mailing

Northwestern University·interventional·Posted Apr 1, 2009·Updated Mar 21, 2023

In Brief

A clinical study evaluating Usual care mailing intervention and CIS support mailing intervention for Precancerous Condition. Completed, enrolled 254 participants across 2 sites.

Detailed Summary

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrecancerous Condition
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 1, 2009
Enrollment StartOct 1, 2006
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 17.3 years ago

Interventions

Usual care mailing interventionother

routine colposcopy reminder letter

CIS support mailing interventionother

Mailed reminder plus provider recommendation to call CIS and sample questions to ask